BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Gardasil regulatory update

FDA did not grant approval of an sBLA from Merck for Gardasil HPV vaccine use in women ages 27-45. Instead, the agency updated the label to state that "Gardasil has not been demonstrated to prevent HPV-related CIN 2/3 or worse...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >